ID
13060
Description
Anti-Angiogenesis Therapy Using Thalidomide in Multiple Myeloma; ODM derived from: https://clinicaltrials.gov/show/NCT00083577
Link
https://clinicaltrials.gov/show/NCT00083577
Keywords
Versions (1)
- 1/13/16 1/13/16 -
Copyright Holder
CC BY-NC 3.0
Uploaded on
January 13, 2016
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Multiple Myeloma NCT00083577
Eligibility Multiple Myeloma NCT00083577
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
active infection
Data type
boolean
Alias
- UMLS CUI [1]
- C0009450
Description
concurrent therapy
Data type
boolean
Alias
- UMLS CUI [1]
- C0039736
Similar models
Eligibility Multiple Myeloma NCT00083577
- StudyEvent: Eligibility
C0700589 (UMLS CUI [2])